Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine - Archive ouverte HAL Access content directly
Journal Articles Vaccines Year : 2021

Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine

Abstract

The mosquito-borne viral disease dengue is a global public health problem causing a wide spectrum of clinical manifestations ranging from mild dengue fever to severe dengue with plasma leakage and bleeding which are often fatal. To date, there are no specific medications to treat dengue and prevent the risk of hemorrhage. Dengue is caused by one of four genetically related but antigenically distinct serotypes DENV-1–DENV-4. The growing burden of the four DENV serotypes has intensified both basic and applied research to better understand dengue physiopathology. Research has shown that the secreted soluble hexameric form of DENV nonstructural protein-1 (sNS1) plays a significant role in the pathogenesis of severe dengue. Here, we provide an overview of the current knowledge about the role of sNS1 in the immunopathogenesis of dengue disease. We discuss the potential use of sNS1 in future vaccine development and its potential to improve dengue vaccine efficiency, particularly against severe dengue illness.
Fichier principal
Vignette du fichier
vaccines-09-00946-v2.pdf (2.31 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03703022 , version 1 (23-06-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Grégorie Lebeau, Alisé Lagrave, Eva Ogire, Lauriane Grondin, Soundary Seriacaroupin, et al.. Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine. Vaccines, 2021, 9 (9), ⟨10.3390/vaccines9090946⟩. ⟨hal-03703022⟩
12 View
37 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More